Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.OSO BioPharmaceuticals Manufacturing (OsoBio), a contract manufacturing organisation (CMO) engaged in biologic and pharmaceutical injectables, has appointed Susan Schniepp as vice president of Quality.
Subscribe to our email newsletter
Schniepp is expected to take up the responsibility for cGMP compliance of OsoBio’s facility.
Additionally, quality-related matters concerning validation as well as regulatory affairs, records and filings fall under her scope of responsibility.
Prior to joining OsoBio, Schniepp served as chairwoman of the Monograph Development, Psychiatrics and Psychoactives Expert Committee for US Pharmacopeia (USP), a non–governmental, official public standards–setting authority for prescription and over–the–counter medicines and other health-care products manufactured or sold in the US.
Apart from this, Schniepp also worked in quality affairs at Abbott Labs, Antisoma, Hospira and Javelin Pharmaceuticals.